More on XLO

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (11/5/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Xilio Therapeutics (NQ:XLO)
Delayed: 7.77 -0.24 (3%)
Prev. Close $8.01  
Open$8.20 
52 Wk High$ 
52 Wk Low$ 
Day High$8.20 
Day Low$7.77 
P/E N/A  
EPS$ 
Volume2,705 

Friends, Peers and Foes (?): ANIK (more...)

Oct 26, 2026 07:30 AM Xilio doses first patient in XTX501 lung cancer trial
Oct 26, 2026 07:30 AM Xilio Therapeutics Announces First Patient Dosed in Phase 1/2 Clinical Trial of XTX501 in Patients with Metastatic NSCLC
Oct 21, 2026 06:05 AM Raymond James Starts Xilio Therapeutics Inc (XLO) at Outperform
Oct 2, 2026 04:33 PM Form 4 Xilio Therapeutics, Inc. For: Oct 01 Filed by: Houvras Yariv
Oct 2, 2026 04:32 PM Form 3 Xilio Therapeutics, Inc. For: Sep 28 Filed by: Houvras Yariv
Oct 2, 2026 04:30 PM Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Sep 28, 2026 07:30 AM Xilio Therapeutics names new chief medical officer
Sep 28, 2026 07:30 AM Xilio Therapeutics Appoints Yariv J. Houvras, M.D., Ph.D. as Chief Medical Officer
Sep 2, 2026 04:30 PM Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aug 14, 2026 12:01 PM Form SCHEDULE 13G/A Xilio Therapeutics, Inc. Filed by: STEMPOINT CAPITAL LP
View All Articles

Entities mentioned with XLO

View All Entities